A new pilot program uses regulated prediction markets and independent data verification to establish public probabilities for ...
Phase 1/2 DELIVER data demonstrated statistically significant dystrophin expression, functional improvements, and a favorable safety profile with z-rostudirsen.
Most obesity drugs do not improve quality of life or heart health, according to a review published online July 8 in The BMJ.
Higher diagnostic accuracy reported for dementia experts vs primary care doctors before disclosure of test results, but not after.